Srivastava et al., 1988 - Google Patents
Recent developments in blood cell labeling researchSrivastava et al., 1988
View PDF- Document ID
- 12717708907652138813
- Author
- Srivastava S
- Straub R
- Meinken G
- Publication year
External Links
Snippet
A number of recent developments in research on blood cell labeling techniques are presented. The discussion relates to three specific areas:(1) a new in vitro method for red blood cell labeling with/sup 99m/Tc;(2) a method for labeling leukocytes and platelets …
- 238000002372 labelling 0 title abstract description 86
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody or an immunoglobulin, or a fragment thereof, e.g. a camelised human single domain antibody, or the Fc fragment of an antibody
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/531—Production of immunochemical test materials
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0111415B1 (en) | Process for making lyophilized radiographic imaging kit | |
Eckelman et al. | Radiopharmaceuticals labelled with technetium | |
DE3850497T2 (en) | METHOD FOR MARKING ANTIBODIES WITH A METALLION. | |
CA1245980A (en) | Physiologic chemical method of labeling protein substances with the radionuclides of indium | |
US4416865A (en) | Radiopharmaceuticals for localization of thromboembolic disease | |
US4647445A (en) | Radiolabelled lipoproteins and method for making same | |
US4707353A (en) | Radiographic imaging agents | |
US5130118A (en) | Methods and materials for the preparation of metal labelled antibody solutions | |
US4272503A (en) | Reductant composition for technetium-99m and method for making technetium-99m labelled ligands | |
US4010251A (en) | Scanning agent composition and use in imaging liver and for biliary function | |
EP0083129A1 (en) | Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments | |
US4443426A (en) | Blood agent | |
US4293537A (en) | Novel chemical method of labeling proteins with 99m Tc-Technetium at physiological condition | |
Bauer et al. | In vivo/in vitro labeling of red blood cells with 99m Tc | |
CA1324317C (en) | Stable radiodiagnostic products, and the preparation thereof | |
EP0169232B1 (en) | Composition for technetium-99m labelling of proteinaceous material | |
Srivastava et al. | Recent developments in blood cell labeling research | |
JPH0445107B2 (en) | ||
Harwig et al. | In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent | |
Srivastava et al. | Current state of the art of blood cell labeling | |
Hnatowich et al. | The importance of pH and citrate concentration on the in vitro and in vivo behavior of radiogallium | |
EP0111414A2 (en) | Radiographic imaging agents | |
Callahan | Radiol&eled Red Blood Cells: Methods and Mechanisms | |
Srivastava et al. | Radiolabeled antiplatelet monoclonal antibodies for the scintigraphic localization of in-vivo thrombi and vascular lesions | |
Srivastava | Radiolabeled red blood cells: Status, problems, and prospects |